Home
TMT
Smart Cars
Gaming
Healthcare
Aerospace
Metaverse
Blockchain
Pfizer
Pfizer withdraws sickle cell disease treatment Oxbryta due to safety concerns
by Christina
Sep.26,2024
Pfizer invests $743m to expand Singapore plant
by Christina
Jul.23,2024
Kansas accuses Pfizer of misleading public about COVID-19 vaccine
by Christina
Jun.18,2024
Texas sues Pfizer for misrepresenting COVID-19 Vaccine efficacy
by Christina
Dec.1,2023
Pfizer & BioNTech Initiate Clinical Trials on Vaccine Targeting Omicron
by Penny
Jan.25,2022
U.S. CDC recommends Pfizer-BioNTech COVID-19 booster for ages 12-15
by Vincy
Jan.6,2022
U.S. FDA said to approve Pfizer-BioNTech COVID-19 booster for ages 12-15
by Vincy
Dec.31,2021
U.S. CDC: Pfizer COVID-19 vaccine causes mostly mild side effects in ages 5-11
by Vincy
Dec.31,2021
S. Korea approves Pfizer's COVID-19 pill for emergency use
by Vincy
Dec.27,2021
Pfizer Covid-19 Pill Receives U.S. FDA Emergency Use Authorization
by Penny
Dec.23,2021
Load More
Weekly Highlights
EHang makes first test flight of eVTOL powered by solid-state battery
Nov.15,2024
Chinese EV maker Leapmotor unveils new car B10
Nov.15,2024
Chinese self-driving firm Pony.ai seeks to raise up to $378 million in U.S. IPO
Nov.15,2024
Ex-Weimob COO joins Google Cloud as president of Greater China
Nov.18,2024
U.S. FTC plans to open investigation into Microsoft's cloud business
Nov.15,2024